Products - Prostate cancer | Topic | NICE

Showing 2 products

Date | Sort by Title

Advice programme: Evidence summariesRemove ‘Advice programme: Evidence summaries’ filter

Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)
Product type:
Advice
Programme:
Evidence summary
Published date:
5 January 2016
Prostate cancer: triptorelin (Decapeptyl SR) (ESNM30)
Product type:
Advice
Programme:
Evidence summary
Published date:
13 January 2014